BridgeMD
New treatment option for Obesity Morbid
Official title Metabolic Effects of a Diet Replaced With Essential Amino Acids
ClinicalTrials.gov ID: NCT06309563
What this study is testing
- What it's testing
- The effectiveness of low-protein diets supplemented with essential aminoacid (EAA) formulas in genetic disorders of amino acid (AA) catabolism, such as maple syrup urine disease (MSUD), is widely recognized (Blackburn PR et al. 2017).
- You might receive a placebo (an inactive treatment) instead of the study drug.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 45 to 65
You may be able to join if
- \- Obesity (BMI \>35kg/m2)
You likely can't join if
- Type 2 diabetes mellitus
- Renal failure
- Heart failure (New York Heart Association NYHA, class IV)
- Liver cirrhosis
- Neoplasms
- Muscular or non-autonomic pathologies
See the full eligibility criteria
- \- Obesity (BMI \>35kg/m2)
- Type 2 diabetes mellitus
- Renal failure
- Heart failure (New York Heart Association NYHA, class IV)
- Liver cirrhosis
- Neoplasms
- Muscular or non-autonomic pathologies
- Neurological-neurodegenerative pathologies
- Cognitive decline
- Non-menopausal women.
- Patients who have undergone bariatric surgery in the previous 12 months
- Patients on pharmacological treatment for weight loss in the last three weeks
- Patients using vitamin and amino acid supplements in the last three weeks
- Patients on hormone therapy (e.g. L-thyroxine, testosterone).
The study team makes the final eligibility decision.
Where it's taking place
- Oggebbio, Verbania, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 45 years to 65 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Oggebbio, Verbania, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.